In CESC, ESCA, GBM, LUSC, and thymoma (THYM), RRM2 had a negative correlation with marker genes of immune activating genes, such as VSTR, TNFSF14, TNFRSF14, and STING1 (Fig. 7A). This evidence concerns the gene RRM2 and glioblastoma.